Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KILITCH DRUGS vs AURO LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KILITCH DRUGS AURO LAB. KILITCH DRUGS/
AURO LAB.
 
P/E (TTM) x 49.0 14.0 350.9% View Chart
P/BV x 4.3 2.9 146.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KILITCH DRUGS   AURO LAB.
EQUITY SHARE DATA
    KILITCH DRUGS
Mar-23
AURO LAB.
Mar-23
KILITCH DRUGS/
AURO LAB.
5-Yr Chart
Click to enlarge
High Rs218116 188.3%   
Low Rs12153 231.0%   
Sales per share (Unadj.) Rs89.684.9 105.5%  
Earnings per share (Unadj.) Rs5.33.9 135.6%  
Cash flow per share (Unadj.) Rs7.65.6 134.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs93.954.9 171.0%  
Shares outstanding (eoy) m15.586.23 250.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.91.0 191.0%   
Avg P/E ratio x31.921.5 148.6%  
P/CF ratio (eoy) x22.414.9 149.8%  
Price / Book Value ratio x1.81.5 117.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,646525 504.0%   
No. of employees `000NANA-   
Total wages/salary Rs m11738 312.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,396529 263.9%  
Other income Rs m299 310.1%   
Total revenues Rs m1,425538 264.7%   
Gross profit Rs m17744 403.6%  
Depreciation Rs m3611 330.6%   
Interest Rs m518 624.4%   
Profit before tax Rs m12034 348.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3710 371.7%   
Profit after tax Rs m8324 339.2%  
Gross profit margin %12.78.3 152.9%  
Effective tax rate %31.129.1 106.6%   
Net profit margin %5.94.6 128.5%  
BALANCE SHEET DATA
Current assets Rs m1,264354 357.3%   
Current liabilities Rs m689181 379.9%   
Net working cap to sales %41.232.6 126.4%  
Current ratio x1.82.0 94.1%  
Inventory Days Days1632 7,060.0%  
Debtors Days Days1,41985,599 1.7%  
Net fixed assets Rs m911206 442.0%   
Share capital Rs m15662 250.0%   
"Free" reserves Rs m1,307280 467.2%   
Net worth Rs m1,462342 427.6%   
Long term debt Rs m020 0.0%   
Total assets Rs m2,175560 388.5%  
Interest coverage x3.45.2 64.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.9 67.9%   
Return on assets %6.15.8 105.7%  
Return on equity %5.77.1 79.3%  
Return on capital %11.711.8 99.4%  
Exports to sales %073.3 0.0%   
Imports to sales %047.3 0.0%   
Exports (fob) Rs mNA388 0.0%   
Imports (cif) Rs mNA250 0.0%   
Fx inflow Rs m602388 155.2%   
Fx outflow Rs m161253 63.6%   
Net fx Rs m441135 327.0%   
CASH FLOW
From Operations Rs m2633 78.8%  
From Investments Rs m79-51 -155.8%  
From Financial Activity Rs m-7-82 8.8%  
Net Cashflow Rs m98-100 -98.1%  

Share Holding

Indian Promoters % 69.2 52.1 132.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.8 47.9 64.2%  
Shareholders   9,062 9,905 91.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KILITCH DRUGS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on KILITCH DRUGS vs AURO LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

KILITCH DRUGS vs AURO LAB. Share Price Performance

Period KILITCH DRUGS AURO LAB. S&P BSE HEALTHCARE
1-Day -0.09% 2.32% 1.18%
1-Month -3.31% -2.72% -0.75%
1-Year 172.81% 189.99% 61.82%
3-Year CAGR 68.56% 25.69% 18.16%
5-Year CAGR 14.41% 22.13% 19.79%

* Compound Annual Growth Rate

Here are more details on the KILITCH DRUGS share price and the AURO LAB. share price.

Moving on to shareholding structures...

The promoters of KILITCH DRUGS hold a 69.2% stake in the company. In case of AURO LAB. the stake stands at 52.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of KILITCH DRUGS and the shareholding pattern of AURO LAB..

Finally, a word on dividends...

In the most recent financial year, KILITCH DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

AURO LAB. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of KILITCH DRUGS, and the dividend history of AURO LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.